Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹-357 Cr₹2,621 Cr₹1,270 Cr₹2,804 Cr₹3,033 Cr

What is the latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-357 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹-357 Cr
Mar2023₹2,621 Cr
Mar2022₹1,270 Cr
Mar2021₹2,804 Cr
Mar2020₹3,033 Cr

How is Total Non-Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹-357 Cr
Negative
Mar2023 ₹2,621 Cr
106.48
Mar2022 ₹1,270 Cr
-54.72
Mar2021 ₹2,804 Cr
-7.56
Mar2020 ₹3,033 Cr -

Compare Total Non-Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses